<?xml version="1.0" encoding="UTF-8"?>
<p id="P69">Ribavirin is approved for the treatment of RSV in children, including hematopoietic stem cell transplant recipients. When used for the treatment of RSV pneumonia, ribavirin is usually given by the aerosol route, which delivers high concentrations at the site of infection.
 <sup>
  <xref ref-type="bibr" rid="R152">152</xref>
 </sup> Oral ribavirin has also been used with good outcomes.
 <sup>
  <xref ref-type="bibr" rid="R153">153</xref>
 </sup> Ribavirin has been used, off-label, for the treatment of HSV, influenza, severe acute respiratory syndrome coronavirus,
 <sup>
  <xref ref-type="bibr" rid="R154">154</xref>,
  <xref ref-type="bibr" rid="R155">155</xref>
 </sup> La Crosse encephalitis,
 <sup>
  <xref ref-type="bibr" rid="R156">156</xref>
 </sup> Nipah encephalitis,
 <sup>
  <xref ref-type="bibr" rid="R157">157</xref>
 </sup> Lassa fever,
 <sup>
  <xref ref-type="bibr" rid="R158">158</xref>
 </sup> hemorrhagic fever with renal syndrome,
 <sup>
  <xref ref-type="bibr" rid="R159">159</xref>
 </sup> Crimean-Congo hemorrhagic fever,
 <sup>
  <xref ref-type="bibr" rid="R160">160</xref>,
  <xref ref-type="bibr" rid="R161">161</xref>
 </sup> Bolivian hemorrhagic fever,
 <sup>
  <xref ref-type="bibr" rid="R162">162</xref>
 </sup> and hantavirus pulmonary syndrome.
 <sup>
  <xref ref-type="bibr" rid="R163">163</xref>
 </sup>
</p>
